Collaborators |
Detail Information
Publications
Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in SpainAline Gauthier
i3 Innovus, Uxbridge, UK
Eur J Public Health 18:674-80. 2008..This study aimed to predict the clinical benefits of introducing a bivalent HPV16/18 vaccine in Spain, where the cervical cancer (CC) incidence is 10.3 per 100 000...
